Source: International Congress 2018 – Emerging and novel imaging biomarkers in drug-induced interstitial lung disease



Rating:

Share or cite this content

Citations should be made in the following way:
J. Wild (Sheffield (South Yorkshire), United Kingdom). Use of MRI for functional and structural assessment of interstitial lung disease. International Congress 2018 – Emerging and novel imaging biomarkers in drug-induced interstitial lung disease

Member's Comments

No comment yet.

Related content which might interest you: 3he MRI and an animal model of interstitial lung disease Source: Annual Congress 2009 - Chest imaging in evolution: new techniques and new possibilities Year: 2009 HRCT in the evaluation of functional decay in IPF Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Ultrasound in the assessment of interstitial lung diseases: Correlation with high-resolution computed tomography and lung functions Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Oxygen enhanced MRI biomarkers of lung function in interstitial lung disease Source: Virtual Congress 2020 – Quantitative imaging in diffuse lung disease Year: 2020 Quantitative CT for the assessment of disease severity in interstitial lung disease Source: Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis? Year: 2020 Lung functional imaging Source: ERS webinar 2021: Lung functional imaging Year: 2021 Correlation of high resolution CT patterns to pulmonary function tests in patients with interstitial lung diseases Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Novel imaging biomarkers for assessment of lung fibrosis and inflammation Source: Virtual Congress 2021 – Emerging imaging biomarkers in lung disease Year: 2021 Understanding the relationship between percentage emphysema as assessed by volumetric CT and lung function in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Multidimensional analysis of respiratory problems Year: 2014 MRI and CT imaging of in vivo models of drug-induced interstitial lung diseases. Source: International Congress 2018 – Emerging and novel imaging biomarkers in drug-induced interstitial lung disease Year: 2018 Ultra-low dose CT in the assessment of diffuse lung disease: Comparison with conventional images Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Visualising regional ventilation heterogeneity by linking multiple breath washout to 3He MRI imaging Source: International Congress 2014 – Functional imaging Year: 2014 Functional evaluation of emphysema using diffusion-weighted 3helium-MRI, HRCT and lung function tests Source: Eur Respir J 2003; 22: Suppl. 45, 532s Year: 2003 Role of imaging in progressive-fibrosing interstitial lung diseases Source: Eur Respir Rev, 27 (150) 180073; 10.1183/16000617.0073-2018 Year: 2018 Proton MRI assessment of lung structure and function in people with cystic fibrosis Source: Virtual Congress 2021 – Novel imaging analysis methodologies in diffuse lung diseases Year: 2021 Quantitative assessment of lung pathology in interstitial lung diseases Source: Eur Respir J 2001; 18: Suppl. 33, 243s Year: 2001 Lung functions and imaging characteristics of the patients with combined pulmonary fibrosis and emphysema Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Early alterations of lung parenchyma in acromegaly Source: International Congress 2014 – Pathophysiological mechanisms at different scales Year: 2014 Linking MRI and CT imaging with lung function measurements in cryptococcal mouse lung infection Source: Annual Congress 2013 –Structural and functional imaging discussion: sometimes different but always linked Year: 2013 Assessment of chest magnetic resonance imaging in non-cystic fibrosis chronic lung disease: comparison to high-resolution computed tomography and correlation with clinical and pulmonary function data Source: Annual Congress 2009 - Paediatric lung function, imaging and methodology in health and disease Year: 2009